top of page

API
PHARMA GRUNDSTOFFE

PORTFOLIO EUROPA & MENA
API Banner.jpg.png

The following is a list of 15 Active Pharmaceutical Ingredients, arranged alphabetically (A–Z). These APIs are manufactured under GMP (Good Manufacturing Practice) conditions. The listed products therefore meet basic quality requirements and can, in principle, also be considered for marketing authorization in Europe & MENA.

Afatinib
06 Afatinib.png

Status: DMF

Specification: In-house

Bendamustine
16 Bendamustine.png

Status: DMF

Specification: In-house

Bortezomib
07 Bortezomib.png

Status: DMF

Specification: In-house

Bosentan
13 Bosentan.png

Status: DMF

Specification: In-house

Clobazam
09 Clobazam.png

Status: DMF

Specification: In-house

14 Dexzoplicone.png
Exzopiclone

Status: DMF

Specification: In-house

Flutamide
05 Flutamide.png

Status: USDMF

Specification: USP43

Gefitinib
08 Gefitinib_S.png

Status: DMF

Specification: In-house

Lifitegrast
18 Lifitegrast.png

Status: DMF

Specification: In-house

Memantine

Status: DMF

Specification: In-house

Minodronic Acid
Minodronic_acid.svg.png

Status: DMF

Specification: In-house

Pimavanserin
10 Pimavanserin.png

Status: DMF

Specification: In-house

Raltitrexed
Raltitrexed.png

Status: DMF

Specification: In-house

Rivaroxaban
02 Rivaroxaban.png

Status: DMF

Specification: In-house

Silibinin
Silibinin_B.png

Status: USDMF

Specification: - 

Tadalafil 

Status: DMF

Specification: In-house

Temozolomide
23 Temozolomide.png

Status: USDMF

Specification: In-house

Teneligliptin
17 Teneligliptin.png

Status: DMF

Specification: In-house

Upadacitinib
18 Upadacitinib.png

Status: DMF

Specification: In-house

Vonoprazan
15 Vonoprazan.png

Status: DMF

Specification: In-house

Zopiclone
11 Zopiclone.png

Status: DMF

Specification: In-house

bottom of page